Belite Bio, Inc Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -5.75M-9.67M-12.65M-31.63M-36.14M
Depreciation and Depletion 0.02M0.03M0.06M0.14M0.16M
Share-based Compensation 1.36M1.53M1.48M3.82M8.99M
Gains from Investment Securities 0.01M0.94M0.27M0.39M
Cash from Operations -4.44M-7.47M-11.46M-29.84M-29.23M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.13M0.26M0.28M
Depreciation & Amortization (CF) 0.02M0.03M0.20M0.40M0.45M
Change in Working Capital
Change in Receivables 0.06M-0.06M
Change in Account Payables -0.02M0.04M-0.04M0.01M
Change in Accured Expenses -0.25M0.63M0.37M1.42M2.46M
Other Working Capital Changes -0.19M0.04M0.64M3.52M1.11M
Investing Activities
Capital Expenditures 0.07M0.39M0.06M0.12M
Sales of Property, Plant and Equipment 0.02M
Change in Intangibles 0.04M
Change in Acquisitions & Divestments 77.84M
Cash from Investing Activities -0.02M-0.06M-0.39M-0.06M-110.57M
Financing Activities
Other financing activities 0.81M1.03M0.88M0.19M
Cash from Financing Activities 28.06M-0.58M36.96M75.96M83.59M
Additional items
Exchange Rate Effect 0.00M-0.16M-0.37M0.01M-0.27M
Change in Cash 23.60M-8.27M24.75M46.07M-56.48M
Beginning Cash Balance 2.45M
Free Cash Flow -4.44M-7.55M-11.85M-29.90M-29.35M
Net Cash Flow 23.60M-8.11M25.11M46.06M-56.21M